Baricitinib therapy response in rheumatoid arthritis patients associates to STAT1 phosphorylation in monocytes.

Front Immunol · 2022 · PMC9357974 · PMID 35958600

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

We showed a trend in monocyte frequency before starting treatment with baricitinib, with lower levels in R patients compared with NR (not significant).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.